Juan Pablo Gutiérrez1, Héctor Sucilla-Pérez2, Carlos J Conde-González3, José Antonio Izazola2, Martín Romero-Martínez1, Mauricio Hernández-Ávila4. 1. Centro de Investigación en Evaluación y Encuestas, Cuernavaca, Morelos, México, 62100, jpgutier@insp.mx. 2. Centro Nacional para la Prevención y Control del VIH/SIDA, México, Distrito Federal, México. 3. Centro de Investigación en Salud Poblacional, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México. 4. Dirección General, Instituto Nacional de Salud Pública, Cuernavaca, Morelos, México.
Abstract
OBJECTIVE: To estimate the HIV seroprevalence among Mexicans aged 15 to 49 years old and living in households, and to describe the profile of serorreactive individuals. MATERIALS AND METHODS: Cross-sectional study with a national probabilistic sample of individuals aged 15 to 49 years with behavioral data from direct interview (face-to-face) at households and HIV screening using capillary blood collected from the same individuals. RESULTS: A seroprevalence of 0.15% (95%CI 0.09-0.21) was estimated for Mexicans aged 15 to 49; seroprevalence among women was 0.07% (95%CI 0.03-0.11) and 0.24% (95%CI 0.11-0.36) for men. HIV serorreactive population is composed of younger men, with a higher socioeconomic level compared to the general population, and with a higher insurance coverage-social protection on health in general and social security in particular. Only 50% of the serorreactive individuals may be aware of their status as living with HIV. CONCLUSIONS: The estimated HIV seroprevalence in the NHNS 2012 suggests a stable pattern since 2000. The estimated prevalence among individuals 15 to 49 years was adjusted both for selection bias correction and to include MSM estimations (under the assumption that MSM is a population hard to reach in a household survey), resulting in a total seroprevalence of 0.23% and an estimated number of people with HIV of 140,000.
OBJECTIVE: To estimate the HIV seroprevalence among Mexicans aged 15 to 49 years old and living in households, and to describe the profile of serorreactive individuals. MATERIALS AND METHODS: Cross-sectional study with a national probabilistic sample of individuals aged 15 to 49 years with behavioral data from direct interview (face-to-face) at households and HIV screening using capillary blood collected from the same individuals. RESULTS: A seroprevalence of 0.15% (95%CI 0.09-0.21) was estimated for Mexicans aged 15 to 49; seroprevalence among women was 0.07% (95%CI 0.03-0.11) and 0.24% (95%CI 0.11-0.36) for men. HIV serorreactive population is composed of younger men, with a higher socioeconomic level compared to the general population, and with a higher insurance coverage-social protection on health in general and social security in particular. Only 50% of the serorreactive individuals may be aware of their status as living with HIV. CONCLUSIONS: The estimated HIV seroprevalence in the NHNS 2012 suggests a stable pattern since 2000. The estimated prevalence among individuals 15 to 49 years was adjusted both for selection bias correction and to include MSM estimations (under the assumption that MSM is a population hard to reach in a household survey), resulting in a total seroprevalence of 0.23% and an estimated number of people with HIV of 140,000.
Authors: Ricardo Baruch-Domínguez; Johanna Chapin-Bardales; Laramie R Smith; Travis H Sánchez; María Zlotorzynska; Ángel B Algarin; Sergio Bautista-Arredondo; Magali Cuadra-Hernández; Mauricio Hernández-Ávila Journal: Salud Publica Mex Date: 2022-06-02
Authors: Catherine E Oldenburg; Katie B Biello; Amaya G Perez-Brumer; Joshua Rosenberger; David S Novak; Kenneth H Mayer; Matthew J Mimiaga Journal: Int J STD AIDS Date: 2016-07-11 Impact factor: 1.359
Authors: Alfonso C Hernández-Romieu; Carlos del Rio; Juan Eugenio Hernández-Ávila; Hugo Lopez-Gatell; José Antonio Izazola-Licea; Patricia Uribe Zúñiga; Mauricio Hernández-Ávila Journal: PLoS One Date: 2016-03-30 Impact factor: 3.240